Back to Search Start Over

Oral Abstract: ABCL-101 Cost-Effectiveness of Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

Authors :
Matthew Matasar
Anthony Masaquel
Rodrigo Ho PharmB
Aino Launonen
Carmen Ng
Rongrong Wang
David Fox
Farah Hossain
Jia Li
Joshua A. Roth
John M. Burke
Source :
Clinical Lymphoma Myeloma and Leukemia. 22:S117
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Subjects

Subjects :
Cancer Research
Oncology
Hematology

Details

ISSN :
21522650
Volume :
22
Database :
OpenAIRE
Journal :
Clinical Lymphoma Myeloma and Leukemia
Accession number :
edsair.doi...........4a026904afd79a9f1d44f929f1be0228
Full Text :
https://doi.org/10.1016/s2152-2650(22)00700-5